NEUCA S.A. (FRA:7HD)

Market Cap	754.69M +3.6%
Revenue (ttm)	3.22B +8.0%
Net Income	40.87M +20.1%
EPS	8.92 +19.1%
Shares Out	n/a
PE Ratio	18.47
Forward PE	15.86
Dividend	3.76 (2.39%)
Ex-Dividend Date	Jul 15, 2025

Volume	n/a
Open	159.20
Previous Close	158.60
Day's Range	159.20 - 159.20
52-Week Range	147.80 - 199.80
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 27, 2026

About NEUCA

NEUCA S.A. engages in the wholesale distribution of pharmaceuticals in Poland. It operates through Wholesale Distribution of Medicines, Manufacture of Pharmaceuticals, Medical Operator, Clinical Trials, and Insurance Activities segments. The company offers Rx, OTC drugs, dietary supplements, medical devices, dermocosmetics, hygiene products, personal protective equipment, as well as diagnostic and dressing materials under the Świat Zdrowia, APTEO, GENOPTIM, CERA+ Solutions, and Kic Kic brands. It also provides medical care services, including p...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1990
• Employees: 5,172
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 7HD

Financial Performance

In 2025, NEUCA's revenue was 13.64 billion, an increase of 8.18% compared to the previous year's 12.61 billion. Earnings were 155.58 million, an increase of 0.87%.

Financial numbers in PLN

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Jun 26, 2026

Data Sources Report a data error